Abeer Shaaban

Has grant

Professor (Hon)

University of Birmingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Abeer Shaaban is an esteemed faculty member at the University of Birmingham in the United Kingdom. Her research focuses on breast cancer pathology and treatment, with recent work addressing topics such as interobserver variability in atypia assessment, prognostic significance of TTK expression, and the implications of HER2-low breast cancer. Professor Shaaban has contributed significantly to the understanding of surgical margins in breast cancer therapy and the pathological changes following neoadjuvant endocrine therapy.

Recent Grants

Grant: Close

A proof of concept, window trial of the Immunological effects of AveLumab and Aspirin in Triple-Negative Breast Cancer.

Open Date: 2016-01-01

Close Date: 2019-01-01

Grant: Close

Investigating the role of terraspanins in inflammatory breast cancer

Open Date: 2014-01-01

Close Date: 2016-01-01

Grant: Close

Inactivation of the PRH/HHEX tumour suppressor and its effects on inflammatory signalling in prostate cancer

Open Date:

Close Date:

Grant: Close

Investigation of the role of CD82/KAI1 in releasing of extracellular vesicles (EVs) with a specific glycosignature to modify the microenvironment and promote homing of breast cancer cells to bone

Open Date:

Close Date:

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

Nigel Bundred

Professor of Surgical Oncology

The University of Manchester

UNITED KINGDOM

View details

Rasha Abu Eid

University of Aberdeen

UNITED KINGDOM

View details

David Dodwell

University of Oxford

UNITED KINGDOM

View details

Adrian Murray Brunt

Professor of Clinical Oncology

Keele University School of Medicine

UNITED KINGDOM

View details

David Muirhead

Senior Lecturer

University of Aberdeen

UNITED KINGDOM

View details

Elinor Sawyer

King’s College London

UNITED KINGDOM

View details

Andrew H. S. Lee

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Abeer Shaaban

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (19)

Diagnostic interobserver variability of atypia assessment in columnar cell lesions among a group of expert breast pathologists in the United Kingdom and the Republic of Ireland, on behalf of the UK national coordinating committee for breast pathology

Threonine and tyrosine kinase (TTK) mRNA and protein expression in breast cancer; prognostic significance in the neoadjuvant setting

HER2-Low Breast Cancer—Current Knowledge and Future Directions

Revisiting surgical margins for invasive breast cancer patients treated with breast conservation therapy - Evidence for adopting a 1 mm negative width

Pathological Changes Following Neoadjuvant Endocrine Therapy (NAET): A Multicentre Study of 391 Breast Cancers

Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models

Detailed Profiling of the Tumor Microenvironment in Ethnic Breast Cancer, Using Tissue Microarrays and Multiplex Immunofluorescence

An Unusual Presentation of Synchronous Breast Cancer and Skin Malignancy in a Patient with Lynch Syndrome: A Case Report and Review of the Literature

Profiling of Tumour-Infiltrating Lymphocytes and Tumour-Associated Macrophages in Ovarian Epithelial Cancer—Relation to Tumour Characteristics and Impact on Prognosis

Tall Cell Carcinoma with Reversed Polarity: Case Report of a Rare Special Type of Breast Cancer and Review of the Literature

Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective

Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma—A Large Multi-Institutional International Study

Pathology of neoadjuvant therapy and immunotherapy testing for breast cancer

Raman spectroscopy: current applications in breast cancer diagnosis, challenges and future prospects

The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project

Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Male breast cancer: an update

Receptor Status after Neoadjuvant Therapy of Breast Cancer: Significance and Implications

Why is LCIS Important—Pathological Review

Collaborators (7)

Nigel Bundred

Rasha Abu Eid

David Dodwell

Adrian Murray Brunt

David Muirhead

Elinor Sawyer

Andrew H. S. Lee

Make your next move.